Conditionally immortalized mouse hepatocytes for use in liver gene therapy
- 1 November 2000
- journal article
- Published by Wiley in Journal of Gastroenterology and Hepatology
- Vol. 15 (11), 1325-1332
- https://doi.org/10.1046/j.1440-1746.2000.2328.x
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Long-term amerlioration of bilirubin glucuronidation defect in gunn rats by transplanting genetically modified immortalized autologous hepatocytesCell Transplantation, 1998
- Treatment of the Crigler–Najjar Syndrome Type I with Hepatocyte TransplantationThe New England Journal of Medicine, 1998
- Identification of bipotential progenitor cells in human liver developmentHepatology, 1996
- Conditional immortalization of gunn rat hepatocytes: Anex vivo model for evaluating methods for bilirubin-UDP-glucuronosyltransferase gene transferHepatology, 1995
- Successful ex vivo gene therapy directed to liver in a patient with familial hypercholesterolaemiaNature Genetics, 1994
- Studies on the Safety of Intrasplenic Hepatocyte Transplantation: Relevance toEx VivoGene Therapy and Liver Repopulation in Acute Hepatic FailureHuman Gene Therapy, 1993
- Hepatocyte cell lines established from transgenic mice harboring temperature-sensitive simian virus 40 large T-antigen geneExperimental Cell Research, 1991
- Permanent engraftment and function of hepatocytes delivered to the liver: Implications for gene therapy and Liver RepopulationHepatology, 1991
- Direct derivation of conditionally immortal cell lines from an H-2Kb-tsA58 transgenic mouse.Proceedings of the National Academy of Sciences of the United States of America, 1991
- Conditional enhancement of liver-specific gene transcription.Proceedings of the National Academy of Sciences of the United States of America, 1988